Healthcare101

 The Global Cell Analysis Market in terms of revenue was estimated to be worth $20.2 billion in 2023 and is poised to reach $33.9 billion by 2028, growing at a CAGR of 10.9% from 2023 to 2028. Attractive Opportunities in the Cell Analysis Market Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946 Cell Analysis Industry Dynamics DRIVER: Growing number of drug discovery activities Adoption of cell-based screening assays has increased in he drug discovery activities to understand associated complexities. Additionally, advances in cell biology, bioinformatics, molecular biology, genomics, and proteomics have generated large volumes of data, owing to which the use of cell-based assays in the drug development process has gained importance. Similarly, the Human Genome Project has generated a number of targets on which drug screening experiments can be carried out. This rapid expansion in drug targets and drug leads in recent years has accelerat...

 The Global Cell Analysis Market in terms of revenue was estimated to be worth $20.2 billion in 2023 and is poised to reach $33.9 billion by 2028, growing at a CAGR of 10.9% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Increase in the preference for cell-bsaed assays along with strong funding for cell-based research is expected to drive the market growth. The conventional methods of toxicity and drug safety assessment (involving animal testing) are expensive, time-consuming, and offer low-throughput. In this regard, modern cell-based assays merge the advantages of cell cultures and animal models to allow researchers to identify problems with lead compounds in early screening, ensuring greater efficiency in the drug discovery and development process. Downloa...

 The report  " Cell Analysis Market  by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Global Forecast to 2028" , is projected to reach USD 33.9 billion by 2028 from USD 20.2 billion in 2023, at a CAGR of 10.9% during the forecast period. ​​​​​​​ ​ Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946 Market Dynamics  Drivers ·         Growing preference for cell-based assays in drug discovery ·         Increasing funding for cell-based research ·         Rising number of drug discovery activities  Restraints ·         High cost of instruments and restrictions on reagent use  Opportunities ·   ...

  Cell Analysis Market   in terms of revenue was estimated to be worth $20.2 billion in 2023 and is poised to reach $33.9 billion by 2028, growing at a CAGR of 10.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. Rising preference for cell-based assays in drug discovery serves as one of the key driving factors of the cell analysis market. Pharmaceutical & biotechnology companies and CROs are replacing biochemical assays with cell-based assays for their lead identification and optimization processes in drug discovery. This is attributive to the several advantages over in vitro biochemical assays. They offer consistent tissue-specific responses in a biologically relevant microenvironment as opposed to biochemical assays. Attractive Opportunities in the Cell Analysis Market Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946 Browse in-depth TOC on "Cell Analysis Market" 233 - Tables 39 - Figures 250 – Pages...